Is Viridian Therapeutics, Inc. (VRDN) a Buy, Sell, or Hold?
NASDAQ : VRDN
Viridian Therapeutics, Inc. — Institutional Ownership
$20.84 USD
$1.53 (7.92%)
- Volume
- 2.17M
- Average Volume
- 2.56M
- Market Capitalization
- $1.88B
- P/E Ratio
- -5.99
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $34.29
- Year Low
- $13.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.15
Institutional Ownership Summary
Institutional Ownership %
2.97%
Investors Holding
34
change: -196 | last: 230
Increased Positions
21
change: -110 | last: 131
Reduced Positions
7
change: -58 | last: 65
New Positions
8
change: -41 | last: 49
Sold Positions
198
change: 145 | last: 53
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -146.1914 | last: 1.4619
Total Invested
55.75M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-26 | Paradigm BioCapital Advisors LP | 5.63M | 5.10% |
| 2026-05-15 | Bellevue Group AG | 6.73M | 6.60% |
| 2026-05-13 | Fairmount Healthcare Fund II GP LLC | 17.2M | 14.04% |
| 2026-05-13 | Fairmount Funds Management LLC | 17.2M | 14.04% |
| 2026-05-08 | Deep Track Capital, LP | 5.42M | 5.30% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Kynam Capital Management, LP | 1.47M | 1.54% |
| 2026-02-13 | Deep Track Capital, LP | 2.52M | 2.65% |
| 2025-11-14 | Commodore Capital LP | 3.2M | 3.90% |
| 2025-10-27 | Fairmount Funds Management LLC | 16.03M | 15.14% |
| 2025-10-27 | Fairmount Healthcare Fund II GP LLC | 16.03M | 15.14% |
| 2025-05-15 | Kynam Capital Management, LP | - | 5.76% |
| 2025-04-11 | Commodore Capital LP | 4.3M | 5.30% |
| 2025-02-14 | Venrock Healthcare Capital Partners III, L.P. | 3.58M | 4.50% |
| 2024-01-29 | Perceptive Life Sciences Master Fund, Ltd. | 4.02M | 6.70% |
| 2024-01-29 | Perceptive Advisors LLC | 4.02M | 6.70% |
| 2024-01-29 | Joseph Edelman | 4.02M | 6.70% |
| 2024-01-24 | STATE STREET CORPORATION | 2.71M | 5.15% |
| 2024-01-10 | FMR LLC | 7.63M | 14.50% |
| 2024-01-10 | Abigail P. Johnson | 7.63M | 14.50% |
| 2023-12-08 | Venrock Opportunities Management, LLC | 2.82M | 5.20% |
| 2023-12-08 | Venrock Opportunities Fund, L.P. | 2.82M | 5.20% |
| 2023-05-11 | Paradigm BioCapital Advisors LP | 2.31M | 5.40% |
| 2023-02-09 | The Vanguard Group - 23-1945930 | 2.11M | 5.25% |
| 2023-02-03 | (1) BlackRock, Inc. | 2.76M | 6.90% |
| 2022-08-12 | Frazier Life Sciences Public Fund, L.P. | 300K | 1.10% |
| 2022-05-31 | Millennium Management LLC | 1.42M | 5.10% |
| 2022-05-31 | Israel A. Englander | 1.42M | 5.10% |
| 2022-05-31 | Millennium Group Management LLC | 1.42M | 5.10% |
| 2022-05-19 | Capital Master LP | 1.37M | 5.00% |
| 2022-05-19 | Capital LP | 1.37M | 5.00% |
| 2022-02-14 | D. E. Shaw & Co., L.P. | 764.61K | 3.50% |
| 2022-02-14 | RA Capital Management, L.P. | - | 0.00% |
| 2022-02-14 | Peter Kolchinsky | - | 0.00% |
| 2022-02-14 | Rajeev Shah | - | 0.00% |
| 2022-02-14 | RA Capital Healthcare Fund, L.P. | - | 0.00% |
| 2022-02-14 | Cormorant Global Healthcare Master Fund, LP | 1.38M | 6.05% |
| 2022-02-14 | Steven A. Cohen | 472.86K | 4.00% |
| 2022-02-14 | Point72 Capital Advisors, Inc. | 472.86K | 4.00% |
| 2022-02-14 | Point72 Asset Management, L.P. | 472.86K | 4.00% |
| 2022-02-14 | Koh, Bong | 2.21M | 9.99% |
| 2022-02-14 | Shah, Nimish | 2.21M | 9.99% |
| 2022-02-14 | 2. | 10.0 | 4.30% |
| 2022-02-14 | 2. | 10.0 | 0.00% |
| 2022-02-14 | 2. | 10.0 | 0.00% |
| 2022-02-14 | 2. | 10.0 | 4.30% |
| 2022-02-14 | VHCP Management EG, LLC | 2.21M | 9.99% |
| 2022-02-14 | L.P. | 2.21M | 9.99% |
| 2022-02-14 | Bihua Chen | 1.44M | 6.28% |
| 2022-02-14 | Cormorant Asset Management, LP | 1.44M | 6.28% |
| 2022-02-14 | Cormorant Global Healthcare GP, LLC | 1.38M | 6.05% |
| 2022-02-14 | David E. Shaw | 764.61K | 3.50% |
| 2022-02-14 | Paradigm BioCapital International Fund Ltd. | 706K | 3.25% |
| 2022-02-14 | D. E. Shaw & Co., L.L.C. | 764.61K | 3.50% |
| 2022-02-14 | D. E. Shaw Valence Portfolios, L.L.C. | 583.67K | 2.70% |
| 2022-02-14 | 2. | 10.0 | 0.00% |
| 2022-02-14 | 2. | 10.0 | 4.30% |
| 2022-02-14 | 2. | 10.0 | 4.30% |
| 2022-02-14 | Logos Global Management LP | - | 11.00% |
| 2022-02-14 | VHCP Management III, LLC | 2.21M | 9.99% |
| 2022-02-14 | Venrock Healthcare Capital Partners EG, L.P. | 2.21M | 9.99% |
| 2022-02-14 | VHCP Co-Investment Holdings III, LLC | 2.21M | 9.99% |
| 2022-02-14 | Dr. Senai Asefaw | 1.21M | 5.57% |
| 2022-02-14 | Paradigm BioCapital Advisors GP LLC | 1.21M | 5.57% |
| 2022-02-14 | Paradigm BioCapital Advisors LP | 1.21M | 5.57% |
| 2022-02-11 | Ally Bridge MedAlpha Master Fund L.P. | 604.77K | 2.80% |
| 2022-02-04 | Hawkes Bay Master Investors (Cayman) L.P. | - | 0.00% |
| 2022-01-28 | Patrick J. Heron | 1.51M | 6.90% |
| 2022-01-28 | Albert Cha | 1.51M | 6.90% |
| 2022-01-28 | James Brush | 1.51M | 6.90% |
| 2022-01-28 | FHMLSP, L.L.C. | 1.51M | 6.90% |
| 2022-01-28 | FHMLSP, L.P. | 1.51M | 6.90% |
| 2022-01-28 | Frazier Life Sciences Public Fund, L.P. | 1.51M | 6.90% |
| 2022-01-28 | James N. Topper | 1.51M | 6.90% |
| 2021-10-28 | Avidity Master Fund LP | 876.58K | 5.20% |
| 2021-10-28 | Avidity Partners Management (GP) LLC | 1.12M | 6.60% |
| 2021-10-28 | David Witzke | 1.12M | 6.60% |
| 2021-10-28 | Avidity Capital Partners (GP) LLC | 1.12M | 6.60% |
| 2021-10-28 | Michael Gregory | 1.12M | 6.60% |
| 2021-10-28 | Avidity Partners Management LP | 1.12M | 6.60% |
| 2021-10-28 | Avidity Capital Partners Fund (GP) LP | 1.12M | 6.60% |
| 2021-10-14 | Shah, Nimish | 1.94M | 9.99% |
| 2021-10-14 | Koh, Bong | 1.94M | 9.99% |
| 2021-10-14 | VHCP Management III, LLC | 1.94M | 9.99% |
| 2021-10-14 | VHCP Co-Investment Holdings III, LLC | 1.94M | 9.99% |
| 2021-10-14 | Venrock Healthcare Capital Partners III, L.P. | 1.94M | 9.99% |
| 2021-10-14 | VHCP Management EG, LLC | 1.94M | 9.99% |
| 2021-10-14 | Venrock Healthcare Capital Partners EG, L.P. | 1.94M | 9.99% |
| 2021-10-08 | Wellington Investment Advisors Holdings LLP | - | 0.00% |
| 2021-10-08 | Wellington Group Holdings LLP | - | 0.00% |
| 2021-10-08 | Wellington Management Group LLP | - | 0.00% |
| 2021-09-30 | Vivo Opportunity, LLC | 1.3M | 7.70% |
| 2021-09-29 | Logos GP LLC | 1.5M | 11.00% |
| 2021-09-29 | Logos Global Master Fund LP | 1.5M | 11.00% |
| 2021-09-29 | Logos Global Management LP | 1.5M | 11.00% |
| 2021-09-29 | Arsani William | 1.5M | 11.00% |
| 2021-09-29 | TCG Crossover Management, LLC | 1.31M | 8.20% |
| 2021-09-29 | Logos Global Management GP LLC | 1.5M | 11.00% |
| 2021-09-24 | Deep Track Capital, LP | 1.82M | 9.90% |
| 2021-09-24 | David Kroin | 1.82M | 9.90% |
| 2021-09-24 | Deep Track Biotechnology Master Fund, Ltd. | 1.82M | 9.90% |
| 2021-09-24 | TCG Crossover Management, LLC | 1.31M | 13.70% |
| 2021-09-10 | TCG Crossover Management, LLC | 914K | 9.50% |
| 2021-08-26 | FHMLSP, L.L.C. | 1.31M | 13.60% |
| 2021-08-26 | FHMLSP, L.P. | 1.31M | 13.60% |
| 2021-08-26 | Frazier Life Sciences Public Fund L.P. | 1.31M | 13.60% |
| 2021-08-26 | Patrick J. Heron | 1.31M | 9.50% |
| 2021-08-26 | James Brush | 1.31M | 13.60% |
| 2021-08-26 | Albert Cha | 1.31M | 13.60% |
| 2021-08-26 | James N. Topper | 1.31M | 13.60% |
| 2021-06-01 | 13-3799946 | 720.37K | 8.50% |
| 2021-06-01 | David E. Shaw | 720.37K | 8.50% |
| 2021-06-01 | 13-4046559 | 540.3K | 6.40% |
| 2021-06-01 | 13-3695715 | 720.37K | 8.50% |
| 2021-05-10 | David E. Shaw | 471.69K | 6.50% |
| 2021-05-10 | 13-3799946 | 471.69K | 6.50% |
| 2021-05-10 | 13-3695715 | 471.69K | 6.50% |
| 2021-03-15 | Peter Kolchinsky | 388.38K | 6.30% |
| 2021-03-15 | RA Capital Management, L.P. | 388.38K | 6.30% |
| 2021-03-15 | RA Capital Healthcare Fund, L.P. | 352.94K | 5.70% |
| 2021-03-15 | Rajeev Shah | 388.38K | 6.30% |
| 2021-03-10 | Wellington Management Group LLP | 578.56K | 11.10% |
| 2021-03-10 | Wellington Investment Advisors Holdings LLP | 578.56K | 11.10% |
| 2021-03-10 | Wellington Group Holdings LLP | 578.56K | 11.10% |
| 2021-03-10 | Wellington Management Company LLP | 578.56K | 11.10% |
| 2021-02-19 | Hawkes Bay Master Investors (Cayman) L.P. | 363.28K | 6.97% |
| 2021-02-16 | 2. | 10.0 | 12.00% |
| 2021-02-16 | Point72 Asset Management, L.P. | 426.16K | 4.00% |
| 2021-02-16 | Point72 Capital Advisors, Inc. | 426.16K | 4.00% |
| 2021-02-16 | Steven A. Cohen | 426.16K | 4.00% |
| 2021-02-16 | 2. | 10.0 | 9.90% |
| 2021-02-16 | 2. | 10.0 | 12.00% |
| 2021-02-16 | 2. | 10.0 | 12.00% |
| 2021-02-16 | 2. | 10.0 | 9.90% |
| 2021-02-16 | 2. | 10.0 | 9.90% |
| 2021-02-16 | 2. | 10.0 | 9.90% |
| 2021-01-19 | Bihua Chen | 459.14K | 9.99% |
| 2021-01-19 | Cormorant Global Healthcare GP, LLC | 459.14K | 9.99% |
| 2021-01-19 | Cormorant Global Healthcare Master Fund, LP | 459.14K | 9.99% |
| 2021-01-19 | Cormorant Asset Management, LP | 459.14K | 9.99% |
| 2021-01-11 | Citadel Advisors Holdings LP | 6.0 | 9.80% |
| 2021-01-07 | ABG Management Ltd. | 929.98K | 9.99% |
| 2021-01-07 | Ally Bridge Group (NY) LLC | 929.98K | 9.99% |
| 2021-01-07 | Ally Bridge MedAlpha Management L.P. | 929.98K | 9.99% |
| 2021-01-07 | Ally Bridge MedAlpha Master Fund L.P. | 929.98K | 9.99% |
| 2021-01-07 | Ally Bridge MedAlpha Management GP, LLC | 929.98K | 9.99% |
| 2021-01-07 | Fan Yu | 929.98K | 9.99% |
| 2021-01-05 | Fairmount Healthcare Fund II GP LLC | 806.14K | 16.65% |
| 2021-01-05 | Fairmount Funds Management LLC | 967.67K | 19.99% |
| 2021-01-05 | Fairmount Healthcare Fund GP LLC | 161.53K | 3.34% |
| 2020-12-17 | Peter Kolchinsky | 451.93K | 11.60% |
| 2020-12-17 | Rajeev Shah | 451.93K | 11.60% |
| 2020-12-17 | RA Capital Management, L.P. | 451.93K | 11.60% |
| 2020-12-17 | RA Capital Healthcare Fund, L.P. | 410.69K | 10.50% |
| 2020-11-09 | Biotechnology Value Fund, L.P. | 7.52M | 9.90% |
| 2020-11-09 | Logos GP LLC | 6M | 11.00% |
| 2020-11-09 | Arsani William | 6M | 11.00% |
| 2020-11-09 | Logos Global Management LP | 6M | 11.00% |
| 2020-11-09 | Logos Global Management GP LLC | 6M | 11.00% |
| 2020-11-09 | Logos Global Master Fund LP | 6M | 11.00% |
| 2020-10-29 | Point72 Capital Advisors, Inc. | 6.5M | 4.00% |
| 2020-10-29 | Steven A. Cohen | 6.5M | 4.00% |
| 2020-10-29 | Point72 Asset Management, L.P. | 6.5M | 4.00% |
| 2020-02-13 | Ari Zweiman | 290K | 1.00% |
| 2020-02-13 | 683 Capital Partners, LP | 290K | 1.00% |
| 2020-02-13 | 683 Capital Management, LLC | 290K | 1.00% |
| 2019-01-03 | 683 CAPITAL PARTNERS, LP | 1.7M | 5.50% |
| 2019-01-03 | ARI ZWEIMAN | 1.7M | 5.50% |
| 2019-01-03 | 683 CAPITAL MANAGEMENT, LLC | 1.7M | 5.50% |
| 2018-11-13 | Abigail P. Johnson | 2.89M | 9.44% |
| 2018-11-13 | Select Biotechnology Portfolio | 2.89M | 9.44% |
| 2018-11-13 | FMR LLC | 2.89M | 9.44% |
| 2018-01-30 | JAFCO SV4 Investment Limited Partnership (“JAFCO SV4”) | 667.28K | 3.00% |
| 2018-01-30 | JAFCO Co., Ltd. | 667.28K | 3.00% |
| 2017-04-03 | JAFCO SV4 Investment Limited Partnership (“JAFCO SV4”) | 1.16M | 5.40% |
| 2017-04-03 | JAFCO Co., Ltd. | 1.16M | 5.40% |
| 2017-03-10 | FMR LLC | 3.12M | 14.67% |
| 2017-02-24 | 01-00893943 | 1.61M | 7.50% |
| 2017-02-24 | 46-3847523 | 500.43K | 2.40% |
| 2017-02-24 | Kyle Lefkoff | 2.11M | 9.90% |
| 2017-02-24 | 01-0893942 | 1.61M | 7.50% |
| 2017-02-24 | 46-3860105 | 500.43K | 2.40% |
| 2017-02-24 | Peter A. Roshko | 500.43K | 9.90% |
| 2017-02-24 | Jonathan L. Perl | 2.11M | 9.90% |
| 2017-02-17 | 10. | 2.71M | 12.70% |
| 2017-02-17 | 10. | 2.71M | 12.70% |
| 2017-02-17 | 10. | 2.71M | 12.70% |
| 2016-01-19 | Martin D. Hoe | - | 0.00% |
| 2016-01-19 | Empery Asset Management, LP | - | 0.00% |
| 2016-01-19 | Ryan M. Lane | - | 0.00% |
| 2015-03-20 | PEIERLS, E. JEFFREY 1 | 681.1K | 9.08% |
| 2015-03-20 | PEIERLS, BRIAN E. 1 | 645.6K | 8.60% |
| 2015-03-06 | HEARTLAND ADVISORS, INC. | 200K | 2.80% |
| 2015-02-20 | Martin D. Hoe | 470K | 6.69% |
| 2015-02-20 | Empery Asset Management, LP | 470K | 6.69% |
| 2015-02-20 | Ryan M. Lane | 470K | 6.69% |
| 2015-02-13 | HEARTLAND ADVISORS, INC. | 191.7K | 5.10% |
| 2015-02-13 | William J. Nasgovitz | 191.7K | 5.10% |
| 2015-02-11 | LFIT-A Trust | 350K | 9.30% |
| 2015-02-11 | LeBow Alpha LLLP | 2.23M | 59.00% |
| 2015-02-11 | LeBow Holdings LLC | 2.23M | 59.00% |
| 2015-02-11 | LeBow 2012 Nevada Trust | 350K | 9.30% |
| 2015-02-11 | Bennett S. LeBow | 2.23M | 59.00% |
VRDN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $31.12 | 84.8M | $2.64B | $212.38M | $50.69M | $2.48B |
| 2024-12-31 | $19.17 | 67.89M | $1.3B | $99.59M | $21.1M | $1.22B |
| 2023-12-31 | $21.78 | 44.76M | $974.77M | $102.83M | $21.05M | $893M |
| 2022-12-31 | $29.21 | 32.09M | $937.27M | $155.58M | $5.26M | $786.95M |
| 2021-12-31 | $19.77 | 11.92M | $235.63M | $42.3M | $1.04M | $194.37M |
| 2020-12-31 | $16.45 | 3.56M | $58.51M | $45.9M | $455K | $13.07M |
| 2019-12-31 | $7.20 | 2.09M | $15.04M | $24.85M | $8.3M | -$1.5M |
| 2018-12-31 | $45.45 | 1.97M | $89.69M | $32.61M | $10.3M | $67.38M |
| 2017-12-31 | $156.45 | 1.28M | $200.72M | $47.44M | $9.92M | $163.2M |
| 2016-12-31 | $75.15 | 721.41K | $54.21M | $3.34M | $1.04M | $51.92M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19.56 | 102.21M | $2B | $176.35M | $51.17M | $1.87B |
| 2025-12-31 | $31.12 | 84.8M | $2.64B | $212.38M | $50.69M | $2.48B |
| 2025-09-30 | $21.58 | 81.78M | $1.76B | $169.65M | $23.82M | $1.62B |
| 2025-06-30 | $13.98 | 81.59M | $1.14B | $117.32M | $21.34M | $1.04B |
| 2025-03-31 | $13.48 | 81.34M | $1.1B | $116.22M | $21.22M | $1B |
| 2024-12-31 | $19.17 | 80.05M | $1.53B | $99.59M | $21.1M | $1.46B |
| 2024-09-30 | $22.75 | 66.42M | $1.51B | $200.32M | $21.11M | $1.33B |
| 2024-06-30 | $13.21 | 63.85M | $843.52M | $107.67M | $20.96M | $756.81M |
| 2024-03-31 | $17.26 | 61.1M | $1.05B | $91.64M | $21.06M | $983.99M |
| 2023-12-31 | $21.78 | 49.68M | $1.08B | $102.83M | $21.05M | $1B |
| 2023-09-30 | $15.34 | 43.65M | $669.66M | $111.6M | $20.82M | $578.89M |
| 2023-06-30 | $23.79 | 43.25M | $1.03B | $87.08M | $5.51M | $947.43M |